Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.

NK cells are enriched in the liver, constituting around a third of intrahepatic lymphocytes. We have previously demonstrated that they upregulate the death ligand TRAIL in patients with chronic hepatitis B virus infection (CHB), allowing them to kill hepatocytes bearing TRAIL receptors. In this stud...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dimitra Peppa, Lorenzo Micco, Alia Javaid, Patrick T F Kennedy, Anna Schurich, Claire Dunn, Celeste Pallant, Gidon Ellis, Pooja Khanna, Geoffrey Dusheiko, Richard J Gilson, Mala K Maini
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2010
Materias:
Acceso en línea:https://doaj.org/article/ffd688712266402aa9a1b4de8190e233
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ffd688712266402aa9a1b4de8190e233
record_format dspace
spelling oai:doaj.org-article:ffd688712266402aa9a1b4de8190e2332021-11-18T06:03:43ZBlockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.1553-73661553-737410.1371/journal.ppat.1001227https://doaj.org/article/ffd688712266402aa9a1b4de8190e2332010-12-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21187913/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374NK cells are enriched in the liver, constituting around a third of intrahepatic lymphocytes. We have previously demonstrated that they upregulate the death ligand TRAIL in patients with chronic hepatitis B virus infection (CHB), allowing them to kill hepatocytes bearing TRAIL receptors. In this study we investigated whether, in addition to their pathogenic role, NK cells have antiviral potential in CHB. We characterised NK cell subsets and effector function in 64 patients with CHB compared to 31 healthy controls. We found that, in contrast to their upregulated TRAIL expression and maintenance of cytolytic function, NK cells had a markedly impaired capacity to produce IFN-γ in CHB. This functional dichotomy of NK cells could be recapitulated in vitro by exposure to the immunosuppressive cytokine IL-10, which was induced in patients with active CHB. IL-10 selectively suppressed NK cell IFN-γ production without altering cytotoxicity or death ligand expression. Potent antiviral therapy reduced TRAIL-expressing CD56(bright) NK cells, consistent with the reduction in liver inflammation it induced; however, it was not able to normalise IL-10 levels or the capacity of NK cells to produce the antiviral cytokine IFN-γ. Blockade of IL-10 +/- TGF-β restored the capacity of NK cells from both the periphery and liver of patients with CHB to produce IFN-γ, thereby enhancing their non-cytolytic antiviral capacity. In conclusion, NK cells may be driven to a state of partial functional tolerance by the immunosuppressive cytokine environment in CHB. Their defective capacity to produce the antiviral cytokine IFN-γ persists in patients on antiviral therapy but can be corrected in vitro by IL-10+/- TGF-β blockade.Dimitra PeppaLorenzo MiccoAlia JavaidPatrick T F KennedyAnna SchurichClaire DunnCeleste PallantGidon EllisPooja KhannaGeoffrey DusheikoRichard J GilsonMala K MainiPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 6, Iss 12, p e1001227 (2010)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Dimitra Peppa
Lorenzo Micco
Alia Javaid
Patrick T F Kennedy
Anna Schurich
Claire Dunn
Celeste Pallant
Gidon Ellis
Pooja Khanna
Geoffrey Dusheiko
Richard J Gilson
Mala K Maini
Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
description NK cells are enriched in the liver, constituting around a third of intrahepatic lymphocytes. We have previously demonstrated that they upregulate the death ligand TRAIL in patients with chronic hepatitis B virus infection (CHB), allowing them to kill hepatocytes bearing TRAIL receptors. In this study we investigated whether, in addition to their pathogenic role, NK cells have antiviral potential in CHB. We characterised NK cell subsets and effector function in 64 patients with CHB compared to 31 healthy controls. We found that, in contrast to their upregulated TRAIL expression and maintenance of cytolytic function, NK cells had a markedly impaired capacity to produce IFN-γ in CHB. This functional dichotomy of NK cells could be recapitulated in vitro by exposure to the immunosuppressive cytokine IL-10, which was induced in patients with active CHB. IL-10 selectively suppressed NK cell IFN-γ production without altering cytotoxicity or death ligand expression. Potent antiviral therapy reduced TRAIL-expressing CD56(bright) NK cells, consistent with the reduction in liver inflammation it induced; however, it was not able to normalise IL-10 levels or the capacity of NK cells to produce the antiviral cytokine IFN-γ. Blockade of IL-10 +/- TGF-β restored the capacity of NK cells from both the periphery and liver of patients with CHB to produce IFN-γ, thereby enhancing their non-cytolytic antiviral capacity. In conclusion, NK cells may be driven to a state of partial functional tolerance by the immunosuppressive cytokine environment in CHB. Their defective capacity to produce the antiviral cytokine IFN-γ persists in patients on antiviral therapy but can be corrected in vitro by IL-10+/- TGF-β blockade.
format article
author Dimitra Peppa
Lorenzo Micco
Alia Javaid
Patrick T F Kennedy
Anna Schurich
Claire Dunn
Celeste Pallant
Gidon Ellis
Pooja Khanna
Geoffrey Dusheiko
Richard J Gilson
Mala K Maini
author_facet Dimitra Peppa
Lorenzo Micco
Alia Javaid
Patrick T F Kennedy
Anna Schurich
Claire Dunn
Celeste Pallant
Gidon Ellis
Pooja Khanna
Geoffrey Dusheiko
Richard J Gilson
Mala K Maini
author_sort Dimitra Peppa
title Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
title_short Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
title_full Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
title_fullStr Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
title_full_unstemmed Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
title_sort blockade of immunosuppressive cytokines restores nk cell antiviral function in chronic hepatitis b virus infection.
publisher Public Library of Science (PLoS)
publishDate 2010
url https://doaj.org/article/ffd688712266402aa9a1b4de8190e233
work_keys_str_mv AT dimitrapeppa blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT lorenzomicco blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT aliajavaid blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT patricktfkennedy blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT annaschurich blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT clairedunn blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT celestepallant blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT gidonellis blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT poojakhanna blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT geoffreydusheiko blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT richardjgilson blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
AT malakmaini blockadeofimmunosuppressivecytokinesrestoresnkcellantiviralfunctioninchronichepatitisbvirusinfection
_version_ 1718424705694695424